AEGLEA BIOTHERAPEUTICS
Summary
Aeglea is a biotechnology company focused on advancing a robust pipeline of antibody therapeutics with the potential to transform the treatment of inflammatory bowel disease.
Deals Overview
No teams exist
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.